Category: Accuray Inc.
Accuray closes its $277 million buyout of TomoTherapy, doubling the radiosurgery device maker's footprint in the radiation oncology space.
Accuray Inc. (NSDQ:ARAY) completed its $277 million acquisition of TomoTherapy Inc. (NSDQ:TOMO), tying the bow on a deal first announced in March 2010.
Toshiba Medical announces the expiration of the initial tender offer period for outstanding shares of Vital Images.
Toshiba Medical Systems Corp. came one step closer the $273 million acquisition of Vital Images Inc. (NSDQ:VTAL) with the announcement that the initial tender offer period had expired.
A total of 11.9 million shares were tendered by expiration time, representing about 72 percent of Vital Images' outstanding common stock on a fully diluted basis.
iRhythm Technologies raises another $15 million, including funds from lead equity round investor St. Jude Medical.
St. Jude Medical’s (NYSE:STJ) partnership with a California-based arrhythmia-diagnostic company is going well enough that it recently poured more money into that startup.
PerkinElmer Inc.'s first quarter profits drop nearly 4 percent despite the company's double digit sales gains; company announces acquisition of genetic analysis software firm Geospiza Inc.
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter's reports.
Here's a quick rundown of a few releases over the past couple days:
GE Healthcare enters takeover deal for cellular imaging company Applied Precision Inc.
GE Healthcare is looking to boost its life sciences portfolio with the acquisition of a cellular imaging firm.
The General Electric Co. (NYSE:GE) unit is planning to buy Seattle area Applied Precision Inc. in a bid to expand its research products and services offering for the pharmaceutical and life science industries, the company said.
Regulatory documents reveal how a struggling TomoTherapy ended up in the hands of Accuray Inc. for a slim 0.66 percent multiple of its 2010 revenues.
Like so many romances, the impending $277 million marriage between Accuray Inc. (NSDQ:ARAY) and TomoTherapy Inc. (NSDQ:TOMO) began on the shores of the Mediterranean, in the beautiful city of Barcelona.
New details on the merger of Accuray and TomoTherapy show similar companies with very different results.
The $300 million engagement of Accuray Inc. (NSDQ:ARAY) and TomoTherapy Inc. (NSDQ:TOMO) might be a case where the fish ate the whale.